Open Training: CFDA Market Access

November 08, 2018 - November 08, 2018 / Europe

Date:  8 November 2018

Location:   Amsterdam Area

Language: Presentations will be in English

Cost: Regular:  € 875.-
         

Subscription: mail to marketing@qservegroup.com
  

Introduction 

Since the Chinese Medical Device Regulation overhaul in 2014, the market has witnessed countless updates in its regulatory rules, technical guidance, and standards. And the recent governmental reorganization where the formal regulatory body, CFDA (China Food & Drug Administration), is integrated into the new CNDA (China National Drug Administration), seems to herald more changes into the current regulatory framework.

New requirements on clinical evidence, China Agent, overseas inspections etc. bring forth both opportunities and challenges for the foreign medical device manufacturers.

The training 

This training will give an overview of the Chinese medical device regulatory landscape and provide details which are essential for a successful product registration in China. New regulatory requirements such as classification, China Agent, vigilance, clinical evaluation and clinical trial etc. will be included in the training as well. 

Program overview

  • Introduction to Chinese regulatory & regulations overview
  • Timeline, planning, and budgeting for CFDA registration;
  • Classification;
  • Registration routes;
  • Submission file;
  • Clinical evaluation and clinical trial;
  • In-China lab testing;
  • China Agent;
  • Vigilance;
  • Dos and Don’ts with CFDA;
  • Questions & Answers;
  • Evaluation of the Course and Closing.

During the course case studies are used to practice the learnings.

Learning objectives

  • Understand the current regulatory framework in China;
  • Learn what is needed for typical planning and budgeting for product registration in China;
  • Learn to classify your medical device and select the appropriate market access route;
  • Learn the high-level submission file requirements;
  • Learn the requirements of clinical evidence;
  • Understand the roles and responsibilities of different stakeholders (e.g. China Agent, CFDA, distributor etc.) in relation to the foreign manufacturer during and after the registration.

Who should attend

The foreign manufacturer who has no or limited CFDA experience. 

 

 

 

The Trainer:

Xiaoli Gou
Post date: August 13, 2018
Tags
Subscribe to the Qserve Newsletter and follow us on LinkedIn
Want more information? Get in touch with us
Information request